LWP
ABBV icon

Legacy Wealth Planning’s AbbVie ABBV Stock Holding History

Legacy Wealth Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$206K Hold
1,532
– – 0.34% 73
2022
Q2 		$235K Sell
1,532
-9
-0.6% -$1.38K 0.34% 72
2022
Q1 		$250K Buy
+1,541
New +$224K 0.29% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legacy Wealth Planning's ABBV Position: Q3 2022 in Review

Legacy Wealth Planning held its AbbVie (ABBV) position steady in Q3 2022 at 1,532 shares worth $206K. The position accounts for 0.34% of the portfolio, ranked #73.

Legacy Wealth Planning first reported a position in ABBV in Q1 2022 and has held it in 3 quarters since. The position peaked at $250K in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Legacy Wealth Planning held 1,532 shares of AbbVie worth $206K as of Q3 2022.
  • Legacy Wealth Planning left its AbbVie share count unchanged in Q3 2022.
  • AbbVie made up 0.34% of Legacy Wealth Planning's portfolio in Q3 2022, its #73 holding.
  • Legacy Wealth Planning first reported a position in AbbVie in Q1 2022 and has held it in 3 quarters since.
  • Legacy Wealth Planning's AbbVie position peaked at $250K in Q1 2022.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Legacy Wealth Planning's 13F filing for Q3 2022, filed 10 Nov 2022.